ME Therapeutics Holding Stock (OTC: METXF)

Latest news for ME Therapeutics Holding (OTC:METXF) Stock

ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME THERAPEUTICS HLDGS by ME THERAPEUTICS HLDGS INC.

ME Therapeutics Holding Inc

Benchmark analyst Bruce Jackson reiterates Unicycive Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UNCY#NASDAQ">UNCY</a>) with a Speculative Buy and maintains $3 price target.

News

Price Target

Reiteration

Analyst Ratings

UNCY

Benchmark Reiterates Speculative Buy on Unicycive Therapeutics, Maintains $3 Price Target

Truist Securities analyst Jamie Cook maintains AECOM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACM#NYSE">ACM</a>) with a Buy and raises the price target from $119 to $129.

Truist Securities Maintains Buy on AECOM, Raises Price Target to $129

Truist Securities analyst Tobey Sommer maintains ICF International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICFI#NASDAQ">ICFI</a>) with a Hold and lowers the price target from $180 to $140.

ICFI

Truist Securities Maintains Hold on ICF International, Lowers Price Target to $140

Wells Fargo analyst Michael Turrin maintains Autodesk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSK#NASDAQ">ADSK</a>) with a Overweight and raises the price target from $340 to $350.

ADSK

Wells Fargo Maintains Overweight on Autodesk, Raises Price Target to $350

Earnings

MOGU

MOGU H1 2025 EPS RMB(2.76) Up From RMB(4.11) YoY; Revenue RMB61.9M Down From RMB83.3M YoY

Truist Securities analyst Tobey Sommer maintains Booz Allen Hamilton (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAH#NYSE">BAH</a>) with a Hold and lowers the price target from $185 to $155.

Truist Securities Maintains Hold on Booz Allen Hamilton, Lowers Price Target to $155

Wells Fargo analyst Aaron Rakers maintains NetApp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTAP#NASDAQ">NTAP</a>) with a Equal-Weight and raises the price target from $135 to $140.

NTAP

Wells Fargo Maintains Equal-Weight on NetApp, Raises Price Target to $140

Truist Securities analyst Tobey Sommer maintains Leidos Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>) with a Buy and lowers the price target from $205 to $185.

LDOS

Truist Securities Maintains Buy on Leidos Holdings, Lowers Price Target to $185

Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) continues its climb toward $100,000, but traders are adopting cautious approaches to prepare <a href="https://www.benzinga.com/money/bitcoin-price-prediction">for potential corrections</a>.
What Happened: Crypto chart analyst Ali Martinez observed a sell signal on Bitcoin's 4-hour chart, indicating a possible brief correction to $97,085. 
However, a candlestick close above $100,470 could invalidate this bearish setup and push BTC to $102,656 or $104,343.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The TD Sequential presents a sell signal on the <a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> 4-hour chart, anticipating a brief correction to $97,085! A candlestick close above $100,470 will invalidate the bearish formation and potentially push <a href="https://twitter.com/hashtag/BTC?src=hash&amp;ref_src=twsrc%5Etfw">#BTC</a> to $102,656 or $104,343. <a href="https://t.co/WiKQTGYNmJ">pic.twitter.com/WiKQTGYNmJ</a>
&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1859873122389983779?ref_src=twsrc%5Etfw">November 22, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
In another tweet, Martinez shared his strategy for protecting capital during Bitcoin&#8217;s next bear market. Predicting a peak between $173,779 and $461,862 by October 2025, he suggests:
<ul>
<li>Selling 25% of holdings between $173,000 &#8211; $200,000.</li>
<li>Selling 30% between $200,000 &#8211; $300,000.</li>
<li>Selling another 30% between $300,000 &#8211; $400,000.</li>
<li>Selling the final 15% if BTC surpasses $400,000.</li>
</ul>
Additionally, Martinez advises traders to employ a 15%-20% trailing stop-loss after Bitcoin reaches $170,000. He underscores a strict deadline: "If Oct 2025 hits, sell—no matter what."
Also Read: <a href="https://www.benzinga.com/general/education/24/11/42125880/if-you-bought-1-worth-of-bitcoin-at-launch-heres-how-much-youd-have-today-2">If You Bought $1 Worth Of Bitcoin At Launch, Here&#8217;s How Much You&#8217;d Have Today</a>
Why It Matters: Martinez <a href="https://x.com/ali_charts/status/1859909759945850904">noted</a> that over 65,000 BTC, worth $6.37 billion, have been withdrawn from exchanges in the past 96 hours.
IntoTheBlock data shows large transaction volume increasing by 47.5% and daily active addresses grew by 27.2%. Transactions greater than $100,000 are up from 13,321 to 18,859 in a single day. Exchanges netflows are down by 4.5%.
Lookonchain data <a href="https://x.com/lookonchain/status/1859671734951252362">highlighted</a> the ten Bitcoin ETFs saw a netflow of 8,585, worth $842.7 million, in one day. BlackRock inflows increased by 6,643 BTC, worth $652.08 million, bringing its total to 481,270 BTC.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42116183/michael-saylor-predicted-bitcoin-to-hit-13-million-if-it-happens-it-will-entail-massive-hyperinflation-analyst-warns">Michael Saylor Predicted Bitcoin To Hit $13 Million — If It Happens, It Will Entail &#8216;Massive Hyperinflation,&#8217; Analyst Warns</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Bitcoin Zeroes In On $100,000, But This Indicator Signals One More Brief Correction

Truist Securities analyst Tobey Sommer maintains Parsons (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSN#NYSE">PSN</a>) with a Buy and lowers the price target from $130 to $110.

Truist Securities Maintains Buy on Parsons, Lowers Price Target to $110

Wells Fargo analyst Andrew Nowinski maintains Elastic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESTC#NYSE">ESTC</a>) with a Overweight and raises the price target from $100 to $135.

ESTC

Wells Fargo Maintains Overweight on Elastic, Raises Price Target to $135

Wells Fargo analyst Chris Carey maintains Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) with a Overweight and raises the price target from $188 to $190.

Wells Fargo Maintains Overweight on Procter & Gamble, Raises Price Target to $190

Truist Securities analyst Tobey Sommer maintains CACI International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CACI#NYSE">CACI</a>) with a Buy and lowers the price target from $650 to $550.

CACI

Truist Securities Maintains Buy on CACI International, Lowers Price Target to $550

Wells Fargo analyst Ike Boruchow maintains Gap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GAP#NYSE">GAP</a>) with a Overweight and raises the price target from $28 to $30.

Wells Fargo Maintains Overweight on Gap, Raises Price Target to $30

Oppenheimer analyst Kristen Owen maintains Deere (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DE#NYSE">DE</a>) with a Outperform and raises the price target from $448 to $477.

Oppenheimer Maintains Outperform on Deere, Raises Price Target to $477

Cantor Fitzgerald analyst Kristen Kluska reiterates Codexis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDXS#NASDAQ">CDXS</a>) with a Overweight and maintains $11 price target.

CDXS

Cantor Fitzgerald Reiterates Overweight on Codexis, Maintains $11 Price Target

WIIM

LGTY

Logility Supply Chain Solutions shares are trading lower after the company reported worse-than-expected Q2 revenue results and issued FY25 revenue guidance below estimates.

Oppenheimer analyst Scott Schneeberger maintains Intuit (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>) with a Outperform and raises the price target from $712 to $722.

INTU

Oppenheimer Maintains Outperform on Intuit, Raises Price Target to $722

Cantor Fitzgerald analyst Prakhar Agrawal reiterates Keros Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KROS#NASDAQ">KROS</a>) with a Overweight.

KROS

Cantor Fitzgerald Reiterates Overweight on Keros Therapeutics

Oppenheimer analyst Ittai Kidron maintains Elastic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESTC#NYSE">ESTC</a>) with a Outperform and raises the price target from $125 to $140.

Comments

ME Therapeutics Holding

News

Latest news for ME Therapeutics Holding (OTC:METXF) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga